Skip to Content


Please click on the protocol number for additional information.

ECOG E1Z11:   Anastrozole in Treating Aromatase Inhibitor Musculoskeletal Symptoms in Female Patients with Stage I-III Breast Cancer

NSABP B-43 :  Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

NSABP B-47:  Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

NSABP B-51:  Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Pfizer Paloma-3:  Palpociclib: Ongoing Trials in the Management of Breast Caner (please contact the research office for more information)

RTOG 1005:  Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

SCUSF 0806:  Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab

SWOG S1007:  Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive Breast Cancer

SWOG S1202:  Duloxetine Hydrochloride to Treat Muscle, Bone, and Joint Pain in Pts W/Early-Stage Breast Cancer Receiving Hormone Therapy

SWOG S1207:  Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer